NCT06580002
- Conditions
- Adnexal Diseases, Blood Protein Disorders, Brain Cancer, +104 more
- Locations
-
- Chao Family Comprehensive Cancer Center, University of California Irvine Orange, California, United States
Clinical trial condition
Urinary Bladder Cancer
Explore clinical trials studying Urinary Bladder Cancer. Study availability and eligibility vary by location and protocol.
30 public trials
8 recruiting studies
Urinary Bladder Cancer trial results
NCT06822010
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +11 more
- Locations
-
- Rutgers Cancer Institute New Brunswick, New Jersey, United States
NCT00872495
- Conditions
- Bladder Neoplasms, Cancer, Female Urogenital Diseases, +12 more
- Locations
-
- Lahey Clinic, Inc. Burlington, Massachusetts, United States
Recruiting
Association of POCD With Circulating Biomarkers in Patients Undergoing TUR of Bladder Tumor
NCT07165236
- Conditions
- Biomarker, Cognition Disorders, Cognitive Decline, +27 more
- Locations
-
- Osijek UH Osijek, Croatia
NCT05621837
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Diseases, +35 more
- Locations
-
- Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy
NCT04861584
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
- Locations
-
- Zhujiang Hospital Guangzhou, Guangdong, China
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Invasive Bladder Cancer, +10 more
- Locations
-
- Amsterdam UMC, VUmc Amsterdam, North Holland, Netherlands
- Amsterdam UMC, AMC Amsterdam, North Holland, Netherlands
- LUMC Leiden, South Holland, Netherlands
NCT05072600
- Conditions
- Bladder Cancer, Bladder Neoplasms, Bladder Tumors, +13 more
- Locations
-
- Peking University First Hospital Beijing, Beijing Municipality, China
Not Yet Recruiting
Multi-Omics-Based Phase Ⅱ Trial of Trastuzumab Rezetecan Plus Camrelizumab for Perioperative Therapy in HER2-Positive Muscle-Invasive Urothelial Carcinoma
NCT07639983
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +10 more
- Locations
-
Not specified
Not Yet Recruiting
Neoadjuvent Dose-dense Gemcitabine and Cisplatin In Muscle Invasive Bladder Cancer
NCT07184021
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
- Locations
-
- Assiut university Hospital-Departement of clinical oncology. Asyut, Egypt